About The Position

FutureSight is seeking a Co-Founder & CEO to lead Veriflow, an AI-native denial management and revenue recovery venture. This is a co-founder partnership with meaningful founder equity, not a salaried executive role. Veriflow AI resolves denied and aged claims end-to-end, embedding outcome-based contingency pricing. Practices pay zero upfront and only pay a cut of the successfully recovered dollars. The target customer profile is practices with $80K+ in annual recoverable claims. The venture is entering a $16B+ Total Addressable Market with a significant whitespace in the mid-market segment, addressing the issue where 30-40% of denied medical claims go uncontested due to lack of staff and capital, resulting in abandoned revenue.

Requirements

  • Direct exposure to healthcare revenue cycle, medical billing, or denial management.
  • Understanding of nuanced differences in denial codes and administrative denials.
  • Intuitive understanding of fragmented systems used by billers (e.g., Tebra, eClinicalWorks, Availity).
  • Previous founding experience at a venture-backed company.
  • Demonstrated success in B2B SaaS go-to-market, including sales and customer engagement.
  • Fundraising fluency, with the ability to develop investor narratives and close capital.
  • Proven ability to attract, develop, and retain top talent.
  • Clear-eyed understanding of the risks and demands of co-founding a venture-backed company.

Responsibilities

  • Set the venture's direction and lead its execution.
  • Refine the Ideal Customer Profile (ICP), pricing model, and product positioning.
  • Lead pilots with practice owners and revenue cycle leaders, convert them to paid engagements, and build the go-to-market motion.
  • Partner with the FutureSight product and engineering team to ship V1 and iterate on user feedback.
  • Lead the seed raise, supported by FutureSight's network and traction.
  • Recruit and lead the founding team, and establish the cultural foundation of the company.

Benefits

  • Founder equity with meaningful ownership from inception.
  • Pre-seed capital committed by FutureSight for early hires and MVP development.
  • Potential for follow-on funding.
  • Studio resources, including embedded design, engineering, growth, and fundraising support from day one.
  • Access to investor and advisor network across healthtech and early-stage capital markets.
  • A true co-creation model in which you operate as CEO with the studio as your partner.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service